SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-27
👔
Olema Pharmaceuticals, Inc.
@OLMA_InsiderForm 4 Filing: Harmon Cyrus Sells $291,162.5 of $OLMA
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Olema Pharmaceuticals, Inc.
Ticker: $OLMA
Transaction Value
$291,162.5
Price/Share: $11.65
transaction date
2026-07-24
Shares: 25,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Harmon Cyrus, holds the title of Director at Olema Pharmaceuticals, Inc..
On 2026-07-24, the insider transacted 25,000 shares.The shares were transacted at a weighted average price of $11.65 per share, resulting in a total market-relevant value of $291,162.5.
Executive Summary Summary
Harmon Cyrus (Director) sold $291K of $OLMA
Post-Transaction Position: 702,770 shares
SEC Accession No: 0001831410-26-000008 (CIK: 1831410)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.